NEW YORK (360Dx) – The 360Dx Index in June climbed 5 percent compared to May, marking the third month in a row of growth for the index, following a 3 percent month-over-month improvement in April and a 7 percent increase in May.

In total, 15 companies' share prices rose last month, paced by Natera (+61 percent), Foundation Medicine (+38 percent), and Genomic Health (+26 percent). Among the 25 companies in the index, share prices of Enzo Biochem (-20 percent), GenMark Diagnostics (-13 percent), and Oxford Immunotec (-11 percent) declined the most.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.